Current Tracers. João V. Vitola, MD, PhD. Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil

Size: px
Start display at page:

Download "Current Tracers. João V. Vitola, MD, PhD. Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil"

Transcription

1 Current Tracers João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil

2 SPECT - Tracer Characteristics

3 TC-99m tracers and protocols One or two day protocols Stress or rest first Stress only ACS imaging

4 Uptake mechanisms

5 Tracers characteristics and Reliability Uptake curve ~ extraction plateau Intracellular dynamics Energy and Resolution

6 Effects of myocardial extraction plateau 0,10 0,08 % Dose.gram tissue 0,06 0,04 99m Tc-Mibi 201 Tl 0,02 0, Coronary flow (ml.min.g -1 )

7 Vasodilator Exercise MIBI Distribution GI uptake

8 GI Uptake Normalized to the gut

9 GI Uptake

10 Time and Food

11 Decreasing Liver Uptake Vitola J et al, J Nucl Cardiol 2001, 8 (6):652-9

12 heart/ liver Dip Exercise (46%) 1.3 ± ± 0.5* Taillefer et al Dip Exer + Dip (23%) 1.3 ± ± 0.6* Vitola et al *p<0.05 Vitola J et al, J Nucl Cardiol 2001, 8 (6):652-9

13 Thallium ~ less GI uptake

14 Thallium Renal extraction Redistributes ~ Better for viability More linear uptake to flow compared to MIBI Where is the Achilles Heel?

15 Typical Effective Doses of Cardiac Studies Effective Dose (msv) Cath 7 Cath CT Angiography SPECT 24 PET Spiral Spiral w. Tube Current Modulation 4 Axial 2 Calcium Score 10 99m Tc Rest- Stress Dual Isotope 4 99m Tc Low-Dose Stress Only Rb Rest- Stress 13 NH 3 Rest- Stress Years of Background Radiation Courtesy Dr Einstein Einstein AJ, JACC 2012; 59: 553

16 Effect of Nuclear Cardiology Scan Protocol on Estimated Cancer Risk Dual Isotope Tc-99m Rest-Stress N-13 ammonia Courtesy Dr Einstein Berrington A. Circulation 2010;122:2403

17 Tc 99m Activities normalized by BMI BMI Injected Activity ~ 2 d protocols mci mci mci mci > 35 15mCi ~ 8 msv

18 PET tracers ATEN. CORRECTION CALCIUM SCORE ANATOMY 64 SLICES PERFUSION (Absolute) VIABILITY LV FUNCT (True Str) Vitola JV, Cerci J, Delbeke D. PET/CT em Cardiologia, Ed. Revinter, Rio de Janeiro, 2010

19 Ammonia Oxygen Rubidium Acetate Unidad PET/CT Ciclotrón UNAM Courtesy of Turku PET Centre Courtesy Erick Alexanderson Courtesy of B&WH Harvard Unidad PET/CT Ciclotrón UNAM

20 Molecular Imaging - flow and metabolism 18 FDG Glucosa 11 C Palmitato IPPA BMIPP Glucógeno ATP ADP AGL K+ ATP ADP Na+ 201 Tl+ 82 Rb+ Misonidazole [O 2 ] 11 C-CGP Glucosa-6-P AGL-CoA Depósitos de lípidos ATP Glucólisis β oxidación Adenosina Piruvato 11 C-HED 18 F Dopamina 18 F NE Lactato Courtesy Erick Alexanderson Krebs 11 C-Acetato Fosforilación oxidativa 15 O 2 11 C-Homocisteína

21 Glycogen Glucose Glucose Hexokinase Glucose-6-P Cell membrane Glycolytic Hexokinase 18- FDG FDG FDG-6-P CELL METABOLISM

22 Cell metabolism using FDG ~ huge in Cancer Pre-therapy Post-therapy CT FDG PET Vitola JV, Delbeke D, et al. Cancer 1996;78:

23 Cyclotron

24 Myocardial Metabolism 80% - Free fatty acid B oxidation...atp +++ Ischemia: increases glycolisis Hiperglicemia...hiperinsul...reduces lipolysis Increases glucose uptake 3-5 x

25 Image Quality and Impact on accuracy Routine AC using PET- CT SPECT 99m Tc-MIBI PET 82 Rb Courtesy of J. Machac-Mt Sinai, NY

26 Future Direction for Cardiac PET Ideal PET MPI Imaging Agent High cardiac uptake with minimal redistribution Near linear myocardial uptake vs. flow up to 5 ml/min/g or more (high first pass extraction fraction) High target to non-target ratio (vs. lung, liver, bowel) Usable for both exercise and pharmacologic stress Usable for quantitation of absolute myocardial flow Available as unit dose ( 18 F-labeled compound) Adapted from: Glover, D and Gropler, R., J. Nucl. Card 14:6 p765-8 Ver. 18Aug 09

27 New PET perfusion tracer labeled with F-18 Chemical Structure of BMS Mitochondrial Complex 1 (MC-1) Inhibitor O N N C l O O 1 8 F 2-tert-Butyl-4-chloro-5-[4-(2- (18F)fluoro-ethoxymethyl)-benzyloxy]-2H-pyridazin-3-one Yu, et al., J Nucl Cardiol. 2007;14(6): Ver. 18Aug 09

28 First Pass Uptake in Isolated Rabbit Hearts 3 BMS (n=4) 201 Tl (n=3) Uptake m Tc-sestamibi (n=3) * * Coronary perfusion flow (ml/min/g) Yu, et al., J Nucl Cardiol. 2007;14(6): * Indicates p<0.05

29 Study Patient BMS SA Stress Rest Stress BMS HLA Stress Rest Rest J. Maddahi, UCLA Stress BMS VLA Rest Ver.18Aug 09

30 What else besides Perfusion and Viability tracers?

31 MIBG (Meta-Iodo-Benzyl-Guanidine) a physiologic analog of the sympathetic nervous system neurotransmitter norepinephrine (NE). OH I NH OH CHCH 2 NH 2 OH CH 2 NH-C-NH 2 NOREPINEPHRINE MIBG

32 Prognostic Significance of 123 I-mIBG Myocardial Scintigraphy in Heart Failure Patients: Results from the Prospective Multicenter International ADMIRE-HF Trial *ADMIRE-HF: AdreView Myocardial Imaging for Risk Evaluation in Heart Failure Jacobson A et al. ACC, 200

33 [ 123 I]mIBG Planar Imaging for Cardiac Assessment Normal innervation NHYA Class II NYHA Class IV H/M ratio:

34 Cardiac Death Event H/M 1.60: 2-year event-free survival 98% Event-free Survival Probability H/M<1.60: 2-year event-free survival 89% Time (days) *p=0.002 vs H/M 1.60

35 Elderly female, stressful event, anterior STEMI normal epicardial vessels 123 MIBG at Rest 99m Tc- MIBI at Rest 90% are women usual post menopausal Villaroel A, Vitola J, Stier A, Dippe T, Cunha C. Expert Rev. Cardiovasc. Ther., 7 (7) 2009

36 Elderly female, stressful event, anterior STEMI normal epicardial vessels 123 MIBG at Rest 99m Tc- MIBI at Rest 90% are women usual post menopausal Villaroel A, Vitola J, Stier A, Dippe T, Cunha C. Expert Rev. Cardiovasc. Ther., 7 (7) 2009

37 Thank you CURITIBA - BRASIL

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas Emerging role of PET in nuclear cardiology Dr. Erick Alexánderson Rosas PET principles e + e - 180 PET/CT Cyclotron Unit UNAM Cyclotron Radiopharmacy PET Camera CT PET PET CT Perfusion Anatomic evaluation

More information

New Developments / Technologies / Protocols in NC

New Developments / Technologies / Protocols in NC New Developments / Technologies / Protocols in NC João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil DISCLOSURES Honorarium Research / Advisor,

More information

The Role of Nuclear Imaging in Heart Failure

The Role of Nuclear Imaging in Heart Failure The Role of Nuclear Imaging in Heart Failure Mouaz H. Al-Mallah, MD MSc FESC Associate Professor of Medicine Consultant Cardiologist and Division Head, Cardiac Imaging King Abdulaziz Cardiac Centre, National

More information

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas Myocardial blood flow PET evaluation and quantification Dr. Erick Alexánderson Rosas Clinical case 62 year old female patient with a history of DM2 and chronic systemic hypertension She complains of progressive

More information

Hybrid Imaging Improving Nuclear Cardiology Practice

Hybrid Imaging Improving Nuclear Cardiology Practice Lippincott Williams & Wilkins, - Nuclear Medicine teaching File, 2009 Hybrid Imaging Improving Nuclear Cardiology Practice João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico

More information

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING RAYMOND TAILLEFER, M.D. FRCP(c), ABNM DIRECTOR, DEPARTMENT OF NUCLEAR MEDICINE HOPITAL ST-JEAN-SUR-RICHELIEU Disclosures to Report: Grant Research Support:

More information

Pharmacological stress agents and protocols

Pharmacological stress agents and protocols Pharmacological stress agents and protocols João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil DISCLOSURES Honorarium Research and Conferences

More information

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN VUMC PET/CT conference 2009 82 Rb Cardiac Perfusion PET 82 Rb is

More information

NUCLEAR CARDIOLOGY UPDATE

NUCLEAR CARDIOLOGY UPDATE Nuclear Cardiology David K. Shelton, Jr., MD NUCLEAR CARDIOLOGY UPDATE No Conflicts. No Disclosures. No Smoking. David K. Shelton UCDMC Nuclear Cardiology Nuclear Cardiology Radionuclide Ventriculography

More information

SPECT CT Current Status and Future Direction Nuclear Cardiology

SPECT CT Current Status and Future Direction Nuclear Cardiology SPECT CT Current Status and Future Direction Nuclear Cardiology BIR London 25 th February 2013 Nik Sabharwal Consultant Cardiologist Oxford Heart Centre nikant.sabharwal@ouh.nhs.uk No conflict of interest

More information

PET myocard perfusion & viability Riemer Slart

PET myocard perfusion & viability Riemer Slart PET myocard perfusion & viability Riemer Slart Nuclear Medicine Physician Dept. of Nuclear Medicine and Molecular Imaging University Medical Center Groningen, the Netherlands Professor in Molecular Imaging,

More information

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82 CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82 Pr Denis AGOSTINI Président du Groupe de Cardiologie Nucléaire et IRM CHU Caen Bordeaux 2006 Cardiac Perfusion-Metabolism Mismatch with PET Cumulative Survival

More information

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and 1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,

More information

Adriano Duatti Department of Chemical and Pharmaceutical Sciences University of Ferrara Via L. Borsari, 46, Ferrara, Italy

Adriano Duatti Department of Chemical and Pharmaceutical Sciences University of Ferrara Via L. Borsari, 46, Ferrara, Italy Adriano Duatti Department of Chemical and Pharmaceutical Sciences University of Ferrara Via L. Borsari, 46, 44121 Ferrara, Italy dta@unife.it adriano.duatti@unife.it Summary Approved tracers for myocardial

More information

The Role of SPECT/ PET

The Role of SPECT/ PET Session 15: Imaging Heart Failure The Role of SPECT/ PET Albert Flotats, MD, FEBNM Hospital de la Santa Creu i Sant Pau, Barcelona Universitat Autònoma de Barcelona HF - Clinical Questions 1. Etiology?

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Comparative Advantages of PET Over SPECT: Is PET Really Better? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas

More information

Positron emission tomography and molecular imaging

Positron emission tomography and molecular imaging Positron emission tomography and molecular imaging EHH, May, 2010 Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi PET Imaging in Medicine MRI CT MRI PET US SPET MEG

More information

New Challenges in Nuclear Cardiology Practice

New Challenges in Nuclear Cardiology Practice New Challenges in Nuclear Cardiology Practice Brian G. Abbott, MD, FACC, FASNC, FAHA President, ASNC 2016 Associate Professor of Medicine Warren Alpert Medical School of Brown University Director, Cardiovascular

More information

Evaluation of IHD in DM, ESRD, Women, Elderly

Evaluation of IHD in DM, ESRD, Women, Elderly Evaluation of IHD in DM, ESRD, Women, Elderly João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil DISCLOSURES Honorarium Research and Conferences

More information

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation. Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation. Ces fonds proviennent essentiellement d industriels travaillant dans les domaines de l imagerie

More information

João V. Vitola, MD, PhD

João V. Vitola, MD, PhD Pharmacologic Stress using A2a Agonist João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil DISCLOSURES Honorarium Research and Conferences in

More information

Advantages of PET Myocardial Imaging

Advantages of PET Myocardial Imaging Advantages of PET Myocardial Imaging Legal Disclaimers These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.

More information

Cardiac PET. John Buscombe

Cardiac PET. John Buscombe Cardiac PET John Buscombe Why PET? Improved resolution-not really required in cardiology Improved sensitivity this may be important-financially as reduced acquisition time Improved attenuation correction-good

More information

Hybrid imaging of the heart

Hybrid imaging of the heart Pärnu (Estonia) Friday, October 10, 2014 8:00-8:30 a.m Hybrid imaging of the heart María José García Velloso Servicio de Medicina Nuclear Clínica Universidad de Navarra mjgarciave@unav.es Hibrid imaging

More information

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors. DEFINITION OF CARDIAC RADIOPHARMACEUTICAL: A radioactive drug which, when administered for purpose of diagnosis of heart disease, typically elicits no physiological response from the patient. Even though

More information

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος Δρ Αναστασία Κίτσιου Διευθύντρια, Καρδιολογική Κλινική, Σισμανόγλειο ΓΝΑ Chair, Education Committee, Section on Nuclear Cardiology & Cardiac CT, EACVI, ESC

More information

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017. Final Compared to 3Q 2017 Rates Medicare Hospital Outpatient Prospective Payment System HOPPS () Nuclear Cardiology Procedures, Radiopharmaceuticals, and Drugs Click here for Link to References: CMS Website

More information

PET for the Evaluation of Myocardial Viability

PET for the Evaluation of Myocardial Viability PET for the Evaluation of Myocardial Viability Myocardial viability assessment is an important part of cardiac PET to assist physicians to decide upon the best surgical or medical procedures. F-18 FDG

More information

Fundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC

Fundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC Fundamentals of Nuclear Cardiology Terrence Ruddy, MD, FRCPC, FACC Objectives To understand the Principles of Nuclear Cardiac Imaging Radiotracers Image acquisition and processing Stress protocols To appreciate

More information

海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan

海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan 2011 Jan Maryland state (MD), USA Maryland state (MD), USA Baltimore city, MD Baltimore city, MD Myocardial Perfusion PET tracers PET Tracers Half life Production First Pass Extraction Kinetic Properties

More information

EDITORIAL. Dual-isotope myocardial perfusion SPECT imaging: Past, present, and future

EDITORIAL. Dual-isotope myocardial perfusion SPECT imaging: Past, present, and future EDITORIAL Dual-isotope myocardial perfusion SPECT imaging: Past, present, and future Tali Sharir, MD, a,b and Piotr Slomka, PhD c,d a b c d Department of Nuclear Cardiology, Assuta Medical Center, Tel

More information

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin Elmer Jasper B. Llanes, M.D. Nuclear Cardiology St. Luke s Medical Center Outline Ideal Physiologic Characteristics of MPI radioactive tracers

More information

PET and PET/CT in CLINICAL CARDIOLOGY

PET and PET/CT in CLINICAL CARDIOLOGY PET and PET/CT in CLINICAL CARDIOLOGY Rob Beanlands,, MD Chief, Division of Cardiology Univ. of Ottawa Tier 1 Chair in Cardiovascular Research Professor Medicine/Radiology Saul & Edna Goldfarb Chair Chief,

More information

Preview of Presentation

Preview of Presentation Preview of Presentation Discuss Healthcare Environment Clinical Implementation of Technical Innovations SNMMI/ASNC Joint Statement on Rb-82 Cardiac PET Imaging Protocol Principles of Rb-82 Cardiac Imaging

More information

Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction

Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction E. Gordon DePuey, M.D. Icahn School of Medicine ant Mt. Sinai New York, NY Disclosures: Grant Support: Michael J. Fox Foundation

More information

SPECT or PET for Cardiovascular Screening in High-Risk Patients

SPECT or PET for Cardiovascular Screening in High-Risk Patients SPECT or PET for Cardiovascular Screening in High-Risk Patients Paeng, Jin Chul MD PhD Department of Nuclear Medicine Seoul National University Hospital Contents Recent Development in SPECT and PET Technology

More information

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging Journal of Nuclear Medicine, published on July 30, 2015 as doi:10.2967/jnumed.115.161661 Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging Richard C. Brunken MD, FACC, FAHA,

More information

Myocardial Perfusion: Positron Emission Tomography

Myocardial Perfusion: Positron Emission Tomography Myocardial Perfusion: Positron Emission Tomography TH. Schindler, MD University Hospitals of Geneva, Cardiovascular Center, Geneva, Switzerland ESC 2010 Stockholm Personal Disclosure Research Grant support

More information

Nuclear Perfusion Imaging of Angina

Nuclear Perfusion Imaging of Angina January 2002 Nuclear Perfusion Imaging of Angina Davin Quinn HMS III Beth Israel Deaconess Medical Center Radiology Department Goals of Presentation Understand what a perfusion scan is Understand what

More information

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF) Evaluation of Myocardial Viability: What Have We Learned from STICH? Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute CSMC 2013 Professor of Medicine David Geffen School of Medicine

More information

Advances in Cardiovascular Molecular Imaging: Hybrid SPECT/CT, PET/CT, and PET/MRI

Advances in Cardiovascular Molecular Imaging: Hybrid SPECT/CT, PET/CT, and PET/MRI Advances in Cardiovascular Molecular Imaging: Hybrid SPECT/CT, PET/CT, and PET/MRI Albert J. Sinusas, MD Professor of Medicine & Radiology Director, Advanced Cardiovascular Imaging Director, Yale Translational

More information

Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease

Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease Editorial Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease Zhonghua Sun Discipline of Medical Imaging, Department of Imaging and Applied

More information

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial

More information

Pearls & Pitfalls in nuclear cardiology

Pearls & Pitfalls in nuclear cardiology Pearls & Pitfalls in nuclear cardiology Maythinee Chantadisai, MD., NM physician Division of Nuclear Medicine, Department of radiology, KCMH Principle of myocardial perfusion imaging (MPI) Radiotracer

More information

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE.

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE. Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE. Nuclear Cardiology I - A remaining need of a functional information on myocardial perfusion II - The future: - combining

More information

CHRONIC CAD DIAGNOSIS

CHRONIC CAD DIAGNOSIS CHRONIC CAD DIAGNOSIS Chest Pain Evaluation 1. Approach to diagnosis of CAD 2. Classification of chest pain 3. Pre-test likelihood CAD 4. Algorithm for chest pain evaluation in women 5. Indications for

More information

Cardiac Imaging Tests

Cardiac Imaging Tests Cardiac Imaging Tests http://www.medpagetoday.com/upload/2010/11/15/23347.jpg Standard imaging tests include echocardiography, chest x-ray, CT, MRI, and various radionuclide techniques. Standard CT and

More information

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI Cardiac Imaging Kimberly Delcour, DO, FACC Director, Cardiac CT Mahi Ashwath, MD, FACC, FASE Director, Cardiac MRI Cardiac Imaging Discuss the clinical applications of and indications for: Cardiac CT Nuclear

More information

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis Update in Nuclear Imaging of Amyloidosis and Sarcoidosis Balaji Tamarappoo MD, PhD, Cedars-Sinai Heart Institute and Biomedical Imaging Research Institute Cedars-Sinai Medical Center Los Angeles, CA, USA.

More information

MINIMIZING RADIATION EXPOSURE

MINIMIZING RADIATION EXPOSURE MINIMIZING RADIATION EXPOSURE FROM MYOCARDIAL PERFUSION IMAGING ASNC 2017 Choosing Wisely Challenge Debra Mahlum, Maureen Vander Kooy, Steven Port, M.D. Aurora Cardiovascular Services Disclosure Information

More information

Rational use of imaging for viability evaluation

Rational use of imaging for viability evaluation EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Challenges and Opportunities for SPECT & PET in 2013: Implementing Latest Acquisition and Processing Protocols Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

Myocardial viability testing. What we knew and what is new

Myocardial viability testing. What we knew and what is new Myocardial viability testing. What we knew and what is new Dr B K S Sastry, MD, DM. CARE Hospitals, Hyderabad What is Viability Viability Dysfunctional myocardium subtended by diseased coronary arteries

More information

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute 62 year old male Anterior STEMI late presentation, occluded

More information

Nuclear Cardiology Reimbursement. Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN

Nuclear Cardiology Reimbursement. Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN Nuclear Cardiology Reimbursement Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN Slides are not to be reproduced without the permission of the author Slides are not to be

More information

Present and Future PET MPI Agents

Present and Future PET MPI Agents Present and Future PET MPI Agents Eyal Mishani, Ph.D. Cyclotron/Radiochemistry Unit Hadassah Hospital Jerusalem Hadassah Ein Kerem Campous Coronary artery disease Coronary artery disease (CAD) is a blockage

More information

Cardiac Positron Emission Tomography

Cardiac Positron Emission Tomography Journal of the American College of Cardiology Vol. 54, No. 1, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.02.065

More information

Cardiovascular Imaging

Cardiovascular Imaging Cardiovascular Imaging Cardiovascular Imaging Cardio and Vascular Imaging Vascularization / Angiogenesis Cardiovascular Imaging metabolic imaging of the heart myocardial perfusion imaging Cardiac CT Vascularization

More information

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Quanta Diagnostico Nuclear Curitiba, Brazil Clinical history Male 63 y.o.,

More information

Disclosure Information

Disclosure Information Coronary CTA Pearls and Pitfalls Ricardo C. Cury, MD, FSCCT, FAHA, FACC Chairman of Radiology Radiology Associates of South Florida Director of Cardiac Imaging Miami Cardiac and Vascular Institute Past-President

More information

PET: quantification of perfusion and beyond

PET: quantification of perfusion and beyond PET: quantification of perfusion and beyond Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi 27.8.2012 1 Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial

More information

msv Stress dose (mci) Stress dose (MBq)

msv Stress dose (mci) Stress dose (MBq) Supplemental Table 1. A Sample Weight Based Dosing for 99m Tc Sestamibi MPI Using a Dedicated Cardiac SPECT Scanner Weight range Rest (mci) Rest (MBq) msv Stress (mci) Stress (MBq) msv Total msv (rest

More information

Molecular Imaging of Coronary Plaques

Molecular Imaging of Coronary Plaques Molecular Imaging of Coronary Plaques Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute CSMC 20113 Professor of Medicine David Geffen School of Medicine at UCLA Zahi A. Fayad,

More information

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures? Keenan Research Centre Li Ka Shing Knowledge Institute Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures? Howard Leong-Poi, MD, FRCPC Associate Professor of Medicine St.

More information

EMPHISIS ON PHYSIOLOGY PHYSIOLOGY REQUIRES TIME QUALITATIVE vs. QUANTITATIVE ISOTOPES TO RADIOPHARMACEUTICALS

EMPHISIS ON PHYSIOLOGY PHYSIOLOGY REQUIRES TIME QUALITATIVE vs. QUANTITATIVE ISOTOPES TO RADIOPHARMACEUTICALS 1926 Herman Blumgard used solutions of radon gas to measure what he called velocity of the circulation. 1927 Blumberg and Soma Weiss wrote article in (Journal of Clinical Investigation) 1929 Werner Forssmann

More information

Radiologic Assessment of Myocardial Viability

Radiologic Assessment of Myocardial Viability November 2001 Radiologic Assessment of Myocardial Viability Joshua Moss, Harvard Medical School Year III Patient EF 66yo female with a 3-year history of intermittent chest pain previously relieved by sublingual

More information

PET MPI Limitations of SPECT MPI

PET MPI Limitations of SPECT MPI Recent Advances in uclear Cardiology The Impact of PET Myocardial Perfusion Imaging and ew Pharmacologic Agents SPECT MPI (Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging) Widely

More information

Rubidium-82 myocardial perfusion PET/CT

Rubidium-82 myocardial perfusion PET/CT Rubidium- myocardial perfusion PET/CT A.M. Scholtens, MD 1 ; P.C. Barneveld, MD 2 Departments of Nuclear Medicine of 1 Meander Medical Center, Amersfoort, the Netherlands, and 2 Jeroen Bosch Hospital,

More information

Reversible defect of 123 I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related area

Reversible defect of 123 I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related area ORIGINAL ARTICLE Annals of Nuclear Medicine Vol. 16, No. 3, 183 187, 2002 Reversible defect of 123 I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related

More information

MD F A F C A C MAS A N S C

MD F A F C A C MAS A N S C Myocardial Perfusion Imaging and Coronary Calcium Scoring: Complimentary or Competitive David Wolinsky MD FACC MASNC Section Head Nuclear Cardiology, Cleveland Clinic Florida Immediate Past President,

More information

Value of Assessment of Viable and Ischemic Myocardium and Techniques Such as MRI, Radionuclide Imaging

Value of Assessment of Viable and Ischemic Myocardium and Techniques Such as MRI, Radionuclide Imaging Chapter 2 Imaging for Viable and Ischemic Myocardium Value of Assessment of Viable and Ischemic Myocardium and Techniques Such as MRI, Radionuclide Imaging Catalin Loghin and K. Lance Gould Introduction

More information

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Which Test When? Avoid the Stress of Stress Testing Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Outline Understand the importance of coronary artery disease assessment Understand the basics

More information

Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department

Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department Recent initiatives of the FANC Michel Biernaux Michel.biernaux@fanc.fgov.be Health Protection Service Health and Environment Department Reminder objectives of the national survey : 1.Review the average

More information

Imaging and heart failure

Imaging and heart failure Imaging and heart failure Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston, St Jude, BMS imaging, GE Healthcare,

More information

Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, May 2008 Vienna International Centre

Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, May 2008 Vienna International Centre Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, 5-95 9 May 2008 Vienna International Centre Evidence-based Nuclear Cardiology: Imaging of CAD The

More information

Challenging Nuclear Cardiology Research: Stimulating Discovery, Validation and Clinical Relevance

Challenging Nuclear Cardiology Research: Stimulating Discovery, Validation and Clinical Relevance Journal of Nuclear Medicine, published on November 16, 2017 as doi:10.2967/jnumed.117.203042 INVITED EDITORIAL Challenging Nuclear Cardiology Research: Stimulating Discovery, Validation and Clinical Relevance

More information

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) A Light in the Dark: Cardiac MRI and Risk Mitigation J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) Dr. Mikolich has NO financial disclosures relative to

More information

CT or PET/CT for coronary artery disease

CT or PET/CT for coronary artery disease CT or PET/CT for coronary artery disease Rotterdam 2012 Juhani Knuuti, MD, PhD, FESC Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi Turku PET Centre University of Turku Åbo Akademi

More information

Detection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve

Detection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve The 2nd International Symposium on Physics, Engineering and Technologies for Biomedicine Volume 2018 Conference Paper Detection Of Functional Significance of Coronary Stenoses Using Dynamic 13 N-Ammonia

More information

Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs?

Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs? Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs? Pierre-Yves MARIE, Médecine Nucléaire, CHU de Nancy PET Gated-SPECT MRI FDG imaging: effect of dietary status fasting

More information

Cardiac NM. John Buscombe

Cardiac NM. John Buscombe Cardiac NM John Buscombe Nuclear Cardiology RNV Tc-99m labelled RBCs MPS Tl-201 Tc-99m MIBI Tc-99m tetrofosmin Rb-82 Others I-123 MIBG C-11 fatty acids Tc-99m HL91 F-18 FDG Is there any money in it In

More information

Assessment of cardiac function using myocardial perfusion imaging technique on SPECT with 99m Tc sestamibi

Assessment of cardiac function using myocardial perfusion imaging technique on SPECT with 99m Tc sestamibi Journal of Physics: Conference Series PAPER OPEN ACCESS Assessment of cardiac function using myocardial perfusion imaging technique on SPECT with 99m Tc sestamibi To cite this article: M R A Gani et al

More information

IAEA International Conference on Integrated Medical Imaging in CV Disease 2013

IAEA International Conference on Integrated Medical Imaging in CV Disease 2013 IAEA International Conference on Integrated Medical Imaging in CV Disease 2013 How to Stress My Patient Choosing the Proper Stress Test Consultant and Advisory Board for Astellas John J. Mahmarian, MD,

More information

I have no financial disclosures

I have no financial disclosures Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic

More information

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine i North West Armed Forces Hospital Tabuk, KSA. 1 Introduction Hibernation: Term coined by Rahimtoola

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time Multisclice CT in combination with functional imaging for CAD Prof. Juhani Knuuti, MD, FESC Turku University Hospital and University of Turku Turku, Finland MSCT and functional imaging for CAD Practical

More information

Cardiac Diagnostics Workshop. Lori Savard NP Cardiology Update 2015

Cardiac Diagnostics Workshop. Lori Savard NP Cardiology Update 2015 Cardiac Diagnostics Workshop Lori Savard NP Cardiology Update 2015 Disclosure of Commercial Support Potential for conflict(s) of interest: none Objectives Increase understanding regarding stable IHD and

More information

The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh

The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh Key points 1) Coronary artery disease in women differs from men in several ways,

More information

Myocardial Perfusion SPECT How to do it E. Moralidis

Myocardial Perfusion SPECT How to do it E. Moralidis Myocardial Perfusion SPECT How to do it E. Moralidis Aristotelian University AHEPA Hospital Thessaloniki Myocardial perfusion SPECT procedure Stress Imaging Data analysis and reporting Myocardial perfusion

More information

Diagnostic and Prognostic Value of Coronary Ca Score

Diagnostic and Prognostic Value of Coronary Ca Score Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium

More information

Nuclear Medicine in Oncology

Nuclear Medicine in Oncology Radiopharmaceuticals Nuclear Medicine in Oncology Practice Pharmaceutical Radionuc lide Function Tumor type Diphosphonates Tc-99m Osteoblast Bone tumor & metast. Ga-citrate Ga-67 Fe-analogue Bronchogenous

More information

Fellows on this rotation are expected to attend nuclear conferences and multimodality imaging conference.

Fellows on this rotation are expected to attend nuclear conferences and multimodality imaging conference. Rotation: Imaging 1 Imaging 1 provides COCATS Level 1 experience for nuclear cardiology (including SPECT and PET) and cardiac CT. Fellows will administer, process, and read cardiac nuclear studies with

More information

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D. The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum David C. Levin, M.D. October 16, 2016 MPI Utilization Rates/1000[includes PET] total radiologists 2014 total

More information

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

Cigna - Prior Authorization Procedure List: Radiology & Cardiology Cigna - Prior Authorization Procedure List: Radiology & Cardiology Product Category CPT Code CPT Code Description Radiology MR 70336 MRI Temporomandibular Joint(s), (TMJ) Radiology CT 70450 CT Head or

More information

Atypical pain and normal exercise test

Atypical pain and normal exercise test Atypical pain and normal exercise test F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history 67-year old male with several coronary risk factors. Atypical

More information

Hospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan.

Hospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan. Volume 1, Issue 1 Image Article Resolution of Inferior Wall Ischemia after Successful Revascularization of LAD Lesion: The Value of Myocardial Perfusion Imaging in Guiding Management of Multi-vessel CAD

More information

NUCLEAR MEDICINE OF HEART AND LUNG

NUCLEAR MEDICINE OF HEART AND LUNG Clinical decision tree in CAD NUCLEAR MEDICINE OF HEART AND LUNG Abnormal pump function Slides of lectures + electronic books: Stress-rest Stress: defect MPI Rest: better or normal Glucose metab? László

More information